Taclonex Related Published Studies
Well-designed clinical trials related to Taclonex (Calcipotriene / Betamethasone Topical)
A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes. [2006.10]
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris. [2006.06]
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris. [2006]
Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial. [2006]
Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. [2003.01]
Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks. [2000.07]
Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement. [1998.09]
Well-designed clinical trials possibly related to Taclonex (Calcipotriene / Betamethasone Topical)
Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet((R))) versus calcipotriol (Daivonex((R))) in the treatment of psoriasis vulgaris: A randomized, multicentre, clinical trial. [2007]
1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study. [2006.09]
Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo. [2006.03]
Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis. [2005.02]
Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris. [2005]
The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial. [2004.09]
A randomized controlled trial to compare calcipotriol with betamethasone valerate for the treatment of cutaneous lichen planus. [2004.06]
Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial. [2004]
Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients. [2003.01]
Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. [2002.08]
A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris. [2002]
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. [2002]
Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: a flow cytometric study. [2001]
Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion. [2000]
Tacrolimus ointment improves psoriasis in a microplaque assay. [1999.07]
Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. [1998.10]
Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. [1998.10]
Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. [1998.07]
Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. [1998.02]
Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group. [1997.01]
Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study. [1996.09]
Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness. [1994]
Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. [1992.05]
Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. [1991.01.26]
Other research related to Taclonex (Calcipotriene / Betamethasone Topical)
Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany. A comparison of calcipotriol/betamethasone (Daivobet/Dovobet/Taclonex) once daily and a morning/evening non-fix combination of calcipotriol and betamethasone. [2007]
Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study. [2002.06]
Topical application of calcipotriene and corticosteroids: combination regimens. [1997.09]
Other possibly related research studies
Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization. [2007]
Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: a comparative study. [2006.07]
[How I treat...topical treatment of plaque type psoriasis by the combination of calcipotriol and betamethasone dipropionate] [2006.03]
Psoriasis treatment in the United States at the end of the 20th century. [2006.04]
Combination topical therapy for the treatment of psoriasis. [2006.03]
Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis. [2006.01]
[The calcipotriol-betamethasone dipropionate association] [2005.11]
Effects of calcipotriol cream and ointment, clobetasol cream and ointment and tretinoin cream on the erythemogenicity of UVB. [2005.11]
Topical halobetasol propionate in the treatment of plaque psoriasis: a review. [2005]
A novel foam vehicle for delivery of topical corticosteroids. [2005.07]
A two-compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity. [2005]
Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris. [2004]
Dermoscopic assessment of long-term topical therapies with potent steroids in chronic psoriasis. [2004.11]
Common diseases/treatment options: treatment options for psoriasis part 1: topical treatments. [2004.07]
Fixed-dose combination therapy for psoriasis. [2004]
Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. [2004.01]
Topical calcipotriol ointment in the treatment of morphea. [2003.12]
Vitamin D and scalp psoriasis. [2002.11]
Vitamin D and topical therapy. [2002.11]
Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis. [2002.06]
Calcipotriol ointment. A review of its use in the management of psoriasis. [2001]
Update on psoriasis therapy: a perspective from the USA. [2000.03]
Somatostatin- and factor XIIIa-immunoreactive cells in psoriasis during clobetasol propionate and calciprotriol treatment. [1999.01]
Allergic contact dermatitis to preservatives in topical medicaments. [1998.12]
Evaluation of cutaneous reactivity to recently marketed dermatologic products. [1996.02]
Effects of calcipotriol and clobetasol-17-propionate on UVB-irradiated human skin: an immunohistochemical study. [1996]
Evaluation of topical antipsoriatic treatment by chromametry, visiometry and 20-MHz ultrasound in the psoriasis plaque test. [1996]
Non-invasive evaluation of topical calcipotriol versus clobetasol in the treatment of psoriasis. [1994.07]
Contact sensitivity in mice: differential effect of vitamin D3 derivative (calcipotriol) and corticosteroids. [1993.05]
Treatment of psoriasis with calcipotriol and other vitamin D analogues. [1992.12]
Vitamin D analogues and psoriasis. [1992.08]
Vitamin D analogues in the treatment of psoriasis. [1992.05]
Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. [1992.03]
Calcipotriol and betamethasone dipropionate for the treatment of psoriasis: a 52-week study. [2007.05]
Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization. [2007]
|
